Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-02

Clinical Trial Update: Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluating LX1031 in subjects with irritable bowel syndrome has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LX1031

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2010-12-02